Phytochemical constituents of medicinal plants encompass a diverse space of chemical scaffolds which can be used for rational design of novel drugs. India is rich with a flora of indigenous medicinal plants that have been used for centuries in traditional Indian medicine to treat human maladies. A comprehensive online database on the phytochemistry of Indian medicinal plants will enable the application of systems biology and cheminformatic approaches towards natural product based drug discovery. In this direction, we here present, IMPPAT, a manually curated database of Indian Medicinal Plants, Phytochemistry, And Therapeutics. IMPPAT contains 1742 Indian medicinal plants, 9596 phytochemicals and 1124 therapeutic uses which span across 27074 plantphytochemical associations and 11514 plant-therapeutic associations. Notably, the curation effort led to a non-redundant in silico chemical library of 9596 phytochemicals with standard chemical identifiers and structure information. Using cheminformatic approaches, we have computed the physicochemical properties and drug-likeliness of the phytochemicals in IMPPAT which led to a filtered subset of 960 potential druggable phytochemicals. Moreover, a comparative analysis against FDA approved drugs suggests that majority of the druggable phytochemicals in IMPPAT are good candidates for novel prospective drugs as they have little or no structural similarity with existing drugs. The IMPPAT database is openly accessible at: https://www.imsc.res.in/~asamal/resources/imppat/home.
Introduction
Natural products continue to play a significant role in pharmaceutical industry [1] [2] [3] [4] as new sources of drugs. However, recently there has been a decline in the number of marketable drugs derived from natural sources 3, 4 . Furthermore, the majority of these drugs fall into already known structural scaffolds as due importance has not been given to unexplored sources of natural products for drug discovery 4 . As a result, lately, there has been significant interest in applying interdisciplinary approaches 5 such as text mining, natural language processing (NLP) 6 , machine learning 7 , cheminformatics 8 , pharmacophore-based virtual screening 9,10 , systems biology 11, 12 , systems pharmacology 13 , network pharmacology 14 to expand the novel chemical scaffold libraries for drug discovery.
India is well known for its practice of traditional medicine and ethnopharmacology 15 . It is noteworthy that traditional Indian medicinal formulations are multi-component mixtures whose therapeutic use is based on empirical knowledge rather than a mechanistic understanding of the active ingredients in the mixture 15 . Until recently, knowledge of traditional Indian medicine including important medicinal plants and their formulations were buried within books such as Indian Materia Medica 16 and Ayurveda Materia Medica 17 . The nondigital nature of this information limited their effective use towards new drug discovery 5 . Hence, digitization of this knowledge into a comprehensive database on Indian medicinal plants, phytochemistry and ethnopharmacology will enable researchers to apply computational approaches towards drug discovery.
Availability of a curated database of plants, their associated natural products and a repository of their chemical structures, can help in in silico drug discovery. In this direction, there has been significant recent progress in the development of databases [18] [19] [20] [21] [22] [23] [24] [25] on natural products with a focus on phytochemistry of edible and herbaceous plants. Examples of such databases include CVDHD 21 , KNAPSACK 22 , Nutrichem 18, 19 , Phytochemica 20 , TCMID 23 and TCM-Mesh 24 We therefore have built a manually curated database, IMPPAT, containing 1742 Indian Medicinal Plants, 9596 Phytochemical constituents, And 1124 Therapeutic uses. In addition, the IMPPAT database has linked Indian medicinal plants to 974 openly accessible traditional Indian medicinal formulations. Importantly, our curation efforts have led to a non-redundant in silico chemical library of 9596 phytochemical constituents for which we have computed physicochemical properties using cheminformatic tools 28 . We then employed cheminformatic approaches to evaluate the drug-likeliness of the phytochemicals in our in silico chemical library using multiple scoring schemes such as Lipinski's rule of five (RO5) 29 , Oral PhysChem Score (Traffic Lights) 30 , GlaxoSmithKline's (GSK's) 4/400 31 , Pfizer's 3/75 32 , Veber rule 33 and Egan rule 34 . We found a subset of 960 phytochemical constituents of Indian medicinal plants that are potentially druggable in our chemical library based on multiple scoring schemes. In summary, the IMPPAT database is a culmination of our efforts to digitize the wealth of information contained within traditional Indian medicine and provides an integrated platform where principles from systems biology and cheminformatics can be applied to accelerate natural product based drug discovery. IMPPAT is openly accessible at: https://www.imsc.res.in/~asamal/resources/imppat/home. Due to the usage of multiple synonyms for medicinal plants across sources, the common names were converted into their scientific species names and the list was manually curated to remove redundancies. The Plant List database 35 (http://www.theplantlist.org/) was used for identifying synonyms of Indian medicinal plants.
Methods

Data collection, curation and processing
Phytochemical composition of Indian medicinal plants.
After compiling a comprehensive list of more than 5000 Indian medicinal plants, we mined literature to gather information on their phytochemical constituents ( Figure 1 ). In the first stage of data mining, we focussed on specialized traditional Indian medicine books [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . From these books [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] traditional Indian medicine such as Siddha and Unani. In the third stage of data mining for phytochemical composition, we performed text mining of abstracts from published research articles in PubMed 46 using natural language processing (NLP) 47 . Using in-house Python scripts, we identified keywords in PubMed abstracts which imply plant-phytochemical associations. We then used the selected keywords to mine PubMed abstracts to identify and incorporate additional references for plant-phytochemical associations in our database. In total, our database captures the phytochemical composition of 1742 Indian medicinal plants ( Supplementary Table S1 ). The 52 and Human Metabolome database (HMDB) 53 . While assigning standard identifiers to phytochemicals in our database, we have chosen the following priority order: Pubchem 48 , CHEBI 49 , CAS, CHEMSPIDER 50 , KNAPSACK 51 , CHEMFACES, FOODB, NIST Chemistry webbook 52 and HMDB 53 . We highlight that this extensive manual curation effort led to the mapping of more than 15000 common names of phytochemicals used across literature sources to a unique set of 9596 standard chemical identifiers. Phytochemicals which could not be mapped to standard chemical identifiers were excluded from our finalized database. Our choice to include only phytochemicals with standard identifiers and structure information was dictated by our goal to investigate the chemistry and druggability of phytochemical formulations, especially in books, and in the future, a significant effort will be needed to digitize and integrate such information into our database.
Database management and network visualization
To construct this database, the compiled and curated data was integrated using MySQL 
Computation of physicochemical properties, druggability and similarity of phytochemicals
Physicochemical properties and druggability. We used FAF-Drugs4 web-service 28 to compute the following physicochemical properties of the phytochemicals: molecular weight, partition coefficient, solubility in water, topological polar surface area, charge of the compound, number of hydrogen bond donors and acceptors, number of rotatable and rigid bonds, number of hetero-and heavy atoms, and number of stereocenters. FAF-Drugs4 web-service 28 tested the druggability of the phytochemicals based on multiple scoring schemes, namely, Lipinski's rule of five (RO5) 29 , Oral PhysChem Score (Traffic Lights) 30 , GlaxoSmithKline's (GSK's) 4/400 31 , Pfizer's 3/75 32 77 score using FAF-QED web-service 28 for the filtered list of druggable phytochemicals. 78 is a widely used measure to compute structural similarity between chemicals 79 . To evaluate the structural similarity of chemicals within our database to known drugs using Tc, we employed two molecular fingerprints: (a) Extended Circular Fingerprints (ECFP4) 80 We obtained a list of 2069 FDA approved drugs from DrugBank 27 and computed their structural similarity with our druggable phytochemicals using both ECFP4 and MACCS keys based molecular fingerprints. Note that ECFP4 molecular fingerprints were used to create the chemical similarity network of the druggable phytochemicals with QEDw score ≥ 0.9. Besides quantifying the structural similarity based on the Tc of phytochemicals, we have employed principal component analysis (PCA) to explore possible relationships between druggable phytochemicals with QEDw score ≥ 0.9 based on their physicochemical properties.
Similarity of phytochemicals. Tanimoto coefficient (Tc)
Results
Web-interface of the database
The IMPPAT database captures information on three types of associations for Indian medicinal plants: phytochemical composition, therapeutic uses, and traditional medicinal formulations ( Figure   1 ). The web-interface of the database enables users to query for each of these associations using (a) scientific names of plants, (b) standard chemical identifiers of phytochemical constituents, (c) therapeutic uses, or (d) formulation identifiers ( Figure 2 ). The web-interface displays the result of user queries for these associations in two ways: (a) A table of associations with references to literature sources, and (b) A network visualization of the associations which is powered by Cytoscape.js 76 (Figure 2 ). In addition, users can also download the result of their queries for different associations of medicinal plants as a tab-separated list using the available export option in the web interface. In the results page of queries for plant-phytochemical associations, users can click each phytochemical name or identifier to navigate to a separate page containing detailed information such as chemical structure, alternate chemical names or identifiers, computed physicochemical properties, computed druggability scores and the option to download the chemical structure file in SDF format (Figure 2 Supplementary Table S1 ). In addition, we identified 15 Indian medicinal plants in Figure 4A gives the number of phytochemicals in IMPPAT that satisfy different druggability scores. From this figure, it is seen that the majority of our phytochemicals satisfy Veber or Egan rules in comparison to Pfizer's 3/75 rule or net Traffic Lights value of zero. Furthermore, we find that the same set of 8712 phytochemicals in IMPPAT satisfy both the Veber rule and Egan rule for drug-likeliness. The vertical bar plot of Figure 4A shows the overlap between sets of phytochemicals that satisfy different druggability scores. We found that 960 out of 9596 phytochemicals in IMPPAT database satisfy all evaluated druggability scores ( Figure 4A ). Subsequently, we designated this filtered list of 960 phytochemicals as (Table 1 ). In Figure 4B , we show the classification of the 960 druggable phytochemicals into broad classes similar to the classification of natural products in NPACT 25 database. It is seen that the subset of 960 druggable phytochemicals is enriched in flavonoids and terpenoids. In Figure 4C , we show the distribution of weighted quantitative estimation of druglikeness (QEDw) score 77 for the 960 druggable phytochemicals. From this figure, it is seen that 14 druggable phytochemical have a QEDw score ≥ 0.9 and 98 druggable phytochemicals have a QEDw score ≥ 0.8.
Overlap with approved drugs space. We obtained the structures of 2069 FDA approved drugs from the DrugBank 27 database. By investigating the structural similarity between FDA approved drugs and 960 druggable phytochemicals in our IMPPAT database, we found that 249 and 302 druggable phytochemicals are similar to FDA approved drugs based on ECFP4 or MACCS keys molecular fingerprints respectively ( Figure 4D; Methods) . Combined, ECFP4 and MACCS keys based fingerprints identified 369 out of 960 druggable phytochemicals that are similar to FDA approved drugs (Methods). Thus, almost 40% of the druggable phytochemicals in IMPPAT database are similar to at least one FDA approved drug which testifies to our systemic approach to identify potential druggable phytochemical constituents of Indian medicinal plants. Importantly, the remaining 591 druggable phytochemicals which have no similarity with any of the FDA approved drugs are novel candidates for designing new drugs based on natural products from Indian medicinal plants.
Chemical similarity network of the most-druggable phytochemicals. For subsequent analysis,
we selected 14 druggable phytochemicals with QEDw score 77 ≥ 0.9 which were designated as the most-druggable phytochemicals. Of these 14 phytochemicals, 12 were found to be similar to at least one of the FDA approved drugs based on either ECFP4 or MACCS keys based molecular fingerprint. The remaining 2 most-druggable phytochemicals, Onosmone (CID:102212116) and
Truxillic acid (CID:78213), were found to have no similarity with any of the FDA approved drugs.
In order to probe the structural diversity of these 14 most-druggable phytochemicals, we computed the Tc based on ECFP4 molecular fingerprint between all pairs of phytochemicals (Methods). In Figure 5A , we display the similarity matrix based on Tc for the 14 most-druggable phytochemicals.
From this figure, it is seen that the majority of the Tc values are small in the similarity matrix implying high structural diversity. Moreover, the similarity matrix can be transformed into a similarity network of phytochemicals by using a stringent threshold value of Tc ≥ 0.5 to determine edges in the graph ( Figure 5B ). We find that only 16 of the 91 possible edges between the 14 mostdruggable phytochemicals are realized in the similarity network ( Figure 5B ). Furthermore, the similarity network can be partitioned into a large connected component (cluster) of 7 phytochemicals, a smaller connected component of 2 phytochemicals and 5 remaining isolated phytochemicals. We highlight that the 2 phytochemicals, Onosmone and Truxillic acid, that have no similarity with any of the FDA approved drugs are among the isolated nodes in the similarity network ( Figure 5B ). Based on plant-phytochemical associations in our database, Onosmone and Truxillic acid are phytochemical constituents of Indian medicinal plants, Onosma echioides and Erythroxylum coca, respectively, and a survey of the literature shows that these phytochemicals are under active investigation for their therapeutic uses [84] [85] [86] [87] [88] . We also highlight that none of the 14 mostdruggable phytochemicals are captured by Phytochemica 20 database while 6 of the 14 phytochemicals are captured by Nutrichem 18, 19 database.
Principal component analysis of the most-druggable phytochemicals based on their
physicochemical properties. In the last section, we studied the similarity between chemical structures of 14 most-druggable phytochemicals to find a large cluster of 7 phytochemicals with highly similar chemical structures. But it is well known that high similarity between chemical structures does not necessarily imply high similarity between chemical activities 89 . Thus, we here investigate the physicochemical properties of the 14 most-druggable phytochemicals. Note that we have used FAF-Drugs4 web-service 28 Figure 5C ). In Figure 5C , the first and second principal components together explained more than 71% of the total variance in the dataset. We find that the 7 most-druggable phytochemicals which are clustered together in the structural similarity space ( Figure 5B ) are not clustered together in the physicochemical or chemical activity space ( Figure   5C ). These observations based on limited analysis of 14 most-druggable phytochemicals suggest that a combined exploration of chemical similarity space and physicochemical or chemical activity space of phytochemical constituents of Indian medicinal plants will be required in the future to identify and design novel drugs.
Discussion and future directions
In the 21 st century, there is immense interest within academia and pharmaceutical industry to incorporate systems biology approaches to accelerate the drug discovery pipeline which has led to the emergence of sub-disciplines such as systems pharmacology 13 and network pharmacology 14 .
Likewise cheminformatics can accelerate drug discovery by aiding in the rational design of robust chemical scaffolds from diverse natural sources 5 In the future, we hope to update IMPPAT database with the following additional information. Firstly, it will be important to link the phytochemical constituents of the Indian medicinal plants with their gene or protein targets. Such target information is vital to obtain a mechanistic understanding of either the therapeutic action or toxic effects of Indian medicinal plants. For example, TCM-Mesh 24 , a traditional Chinese medicine database has gathered gene or protein target information for phytochemical constituents of Chinese medicinal plants using a network pharmacology approach. Importantly, information on gene or protein targets of phytochemicals will also enable pathway level assessment of the therapeutic action of medicinal plants which will help design robust drug scaffolds for many complex diseases. Secondly, it will be important to update our database with more detailed information on the parts of the Indian medicinal plants such as leaves, stem or root, that produce the different phytochemical constituents.
Such detailed information on the phytochemical composition of parts of Indian medicinal plants will be crucial for evaluating and developing traditional Indian medicine formulations 75 
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